Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression

  1. Amarnath Maitra,
  2. Fang Shen,
  3. Walter Hanel,
  4. Karen Mossman,
  5. Joel Tocker§,
  6. David Swart§, and
  7. Sarah L. Gaffen,,
  1. Departments of Oral Biology and
  2. Microbiology and Immunology, University at Buffalo, State University of New York, Buffalo, NY 14214;
  3. §Department of Inflammation Research, Amgen, Inc., Seattle, WA 98119; and
  4. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada L8N 3Z5
  1. Edited by Laurie H. Glimcher, Harvard Medical School, Boston, MA, and approved March 19, 2007 (received for review December 27, 2006)

Abstract

IL-17 is the founding member of a novel family of proinflammatory cytokines that defines a new class of CD4+ effector T cells, termed “Th17.” Mounting evidence suggests that IL-17 and Th17 cells cause pathology in autoimmunity, but little is known about mechanisms of IL-17RA signaling. IL-17 through its receptor (IL-17RA) activates genes typical of innate immune cytokines, such as TNFα and IL-1β, despite minimal sequence similarity in their respective receptors. A previous bioinformatics study predicted a subdomain in IL-17-family receptors with homology to a Toll/IL-1R (TIR) domain, termed the “SEFIR domain.” However, the SEFIR domain lacks motifs critical for bona fide TIR domains, and its functionality was never verified. Here, we used a reconstitution system in IL-17RA-null fibroblasts to map functional domains within IL-17RA. We demonstrate that the SEFIR domain mediates IL-17RA signaling independently of classic TIR adaptors, such as MyD88 and TRIF. Moreover, we identified a previously undescribed“TIR-like loop” (TILL) required for activation of NF-κB, MAPK, and up-regulation of C/EBPβ and C/EBPδ. Mutagenesis of the TILL domain revealed a site analogous to the LPSd mutation in TLR4, which renders mice insensitive to LPS. However, a putative salt bridge typically found in TIR domains appears to be dispensable. We further identified a C-terminal domain required for activation of C/EBPβ and induction of a subset IL-17 target genes. This structure-function analysis of a IL-17 superfamily receptor reveals important differences in IL-17RA compared with IL-1/TLR receptors.

Footnotes

  • To whom correspondence should be addressed. E-mail: sgaffen{at}buffalo.edu
  • Author contributions: A.M., F.S., and W.H. contributed equally to this work; A.M., F.S., W.H., and S.L.G. designed research; A.M., F.S., W.H., and S.L.G. performed research; A.M., F.S., and W.H. analyzed data; K.M., J.T., and D.S. contributed new reagents/analytic tools; and S.L.G. wrote the paper.

  • Conflict of interest statement: J.T. and D.S. own stock in Amgen.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0611589104/DC1.

  • Abbreviations:
    C/EBP,
    CCAAT/Enhancer binding protein;
    FL,
    full length;
    RA,
    rheumatoid arthritis;
    SEFIR,
    SEF/IL-17R domain;
    TILL,
    TIR-like loop;
    TIR,
    Toll/IL-1 receptor domain.
« Previous | Next Article »Table of Contents